Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients

Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma

(2013) Yao-Chun Hsu et al.   HEPATOLOGY

Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: A 10-year nationwide cohort study

(2012) Yao-Chun Hsu et al.   HEPATOLOGY

APASL consensus statements and management algorithms for hepatitis C virus infection

(2012) Masao Omata et al.   Hepatology International

Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection

(2012) Chun-Ying Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

(2011) Goodarz Danaei et al.   LANCET

Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis

(2011) B. Feng et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Changes in Insulin Sensitivity and Body Weight During and After Peginterferon and Ribavirin Therapy for Hepatitis C

(2010) Hari S. Conjeevaram et al.   GASTROENTEROLOGY

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

(2010) Ming-Lung Yu et al.   HEPATOLOGY

Effective Reduction of Gastric Cancer Risk With Regular Use of Nonsteroidal Anti-Inflammatory Drugs in Helicobacter Pylori–Infected Patients

(2010) Chun-Ying Wu et al.   JOURNAL OF CLINICAL ONCOLOGY

Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C

(2009) Ester Vanni et al.   HEPATOLOGY

The global burden of hepatitis C

(2009) Daniel Lavanchy   LIVER INTERNATIONAL

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Pegylated Interferon‐α‐2a plus Ribavirin for Treatment‐Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial

(2008) Chen‐Hua Liu et al.   CLINICAL INFECTIOUS DISEASES

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

(2008) Bart J. Veldt et al.   HEPATOLOGY

Hepatitis C virus infection: Molecular pathways to metabolic syndrome

(2008) Muhammad Y. Sheikh et al.   HEPATOLOGY

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

(2008) Yasuji Arase et al.   HEPATOLOGY

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

(2007) Rami Moucari et al.   GASTROENTEROLOGY